Pittsburgh Penguins general manager Kyle Dubas wants no talk of tanking and quickly pushed back on any insinuations to the ...

Western Midstream remains a top pick with a nearly 9% yield and strong 17.8% return, offering income potential in the MLP ...

An analysis of India’s merger control under CCI rules, deal value threshold, key cases, and comparisons with US, EU, and UK ...

Following the FDA ODAC's vote against belantamab mafodotin-based combinations in relapsed/refractory multiple myeloma, George Mulligan, PhD, provides insight into the agent's potential path foward.

While the U.S. stock market has rebounded, the combination of the Trump tariffs, a volatile dollar and an erratic bond market ...

Corina Dutcus, SVP, oncology global clinical development lead at Eisai, discusses the potential of the E7386 and lenvatinib ...

The FDA's ODAC voted that the benefit-risk profile of belantamab mafodotin in multiple myeloma were not favorable, ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

Aggressive hybrid funds offer a mix of equity and debt, making them ideal for investors seeking moderate risk with growth. They provide built-in tax efficiency and automatic portfolio rebalancing, ...

Learn how striking the right balance with plant growth regulators can reduce fruit drop in 'Honeycrisp' without sacrificing ...

MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...